Global n= 1,372 | Survivors n= 846 (61.7%) | Nonsurvivors n= 526 (38.3%) | P | |
---|---|---|---|---|
General data | ||||
Sex (male) | 837 (61.0%) | 489 (57.8%) | 348 (66.2%) | 0.002 |
Age (years) | 62.2 ± 16.2 | 59.80 ± 16.81 | 66.16 ± 14.39 | <0.001 |
APACHE II | 21.4 ± 7.5 | 19.20 ± 6.86 | 25.09 ± 7.17 | <0.001 |
Lactate (mM) | 35.6 ± 26.9 | 31.09 ± 22.54 | 43.09 ± 31.69 | <0.001 |
Type of infection | ||||
Pneumonia | 502 (36.6%) | 289 (34.2%) | 213 (40.5%) | |
Abdominal | 390 (28.4%) | 228 (27%) | 162 (30.8%) | |
Urologic | 181 (13.3%) | 142 (16.8%) | 40 (7.6%) | |
Meningitis | 50 (3.6%) | 40 (4.7%) | 10 (1.9%) | <0.001 |
Skin and soft-tissue | 54 (3.9%) | 37 (4.4%) | 17 (3.2%) | |
Catheter | 24 (1.7%) | 15 (1.8%) | 9 (1.7%) | |
Others | 138 (10.1%) | 78 (9.2%) | 60 (11.4%) | |
More than one focus | 32 (2.3%) | 17 (2%) | 15 (2.9%) | |
Community acquired | 1,022 (74.5%) | 666 (78.7%) | 356 (67.7%) | <0.001 |
DCCT | 388 (28.3%) | 256 (30.3%) | 132 (25.1%) | 0.042 |